[Clinical study in myasthenia gravis--clinical analysis and follow-up of 113 cases].
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004491:Edrophonium; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007564:Japan; D008297:Male; D008598:Menstruation; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology / Q000532:radiotherapy / Q000601:surgery; D011247:Pregnancy; D011248:Pregnancy Complications; D013934:Thymectomy; D013953:Thymus Neoplasms / Q000150:complications; D013959:Thyroid Diseases / Q000150:complications; D013961:Thyroid Gland / Q000503:physiopathology
D002800:Cholinesterase Inhibitors; D004491:Edrophonium; D000324:Adrenocorticotropic Hormone